Laurion Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-20,000
Closed -$6.33M 920
2020
Q1
$6.33M Sell
20,000
-10,800
-35% -$3.28M 0.07% 212
2019
Q4
$9.14M Sell
30,800
-174,000
-85% -$48.3M 0.07% 231
2019
Q3
$47.7M Sell
204,800
-93,400
-31% -$21.7M 0.35% 60
2019
Q2
$69.7M Buy
+298,200
New +$68.9M 0.69% 35
2019
Q1
Sell
-176,600
Closed -$53.1M 867
2018
Q4
$53.1M Buy
176,600
+136,700
+343% +$43.6M 0.94% 10
2018
Q3
$14.1M Buy
39,900
+29,900
+299% +$10.3M 0.14% 165
2018
Q2
$2.9M Hold
10,000
0.02% 496
2018
Q1
$2.74M Sell
10,000
-55,000
-85% -$17.1M 0.02% 544
2017
Q4
$20.7M Sell
65,000
-47,100
-42% -$15.1M 0.1% 199
2017
Q3
$35.1M Buy
112,100
+47,100
+72% +$13.9M 0.16% 112
2017
Q2
$17.6M Sell
65,000
-25,000
-28% -$6.61M 0.1% 203
2017
Q1
$24.6M Buy
+90,000
New +$25.4M 0.18% 136
2016
Q4
Sell
-7,400
Closed -$2.32M 1108
2016
Q3
$2.32M Buy
+7,400
New +$2.19M 0.02% 460
2014
Q4
Sell
-30,000
Closed -$9.92M 313
2014
Q3
$9.92M Hold
30,000
0.21% 111
2014
Q2
$9.46M Buy
+30,000
New +$9.03M 0.2% 139

Other funds holding BIIB

Laurion Capital Management's BIIB Position: Q1 2026 in Review

Laurion Capital Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 5,033 shares — an estimated $886K sold.

Laurion Capital Management first reported a position in BIIB in Q1 2016 and held it in 19 quarters. The position peaked at $39.6M in Q4 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Laurion Capital Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Laurion Capital Management sold 5,033 Biogen shares in Q1 2026, an estimated $886K.
  • Laurion Capital Management first reported a position in Biogen in Q1 2016 and held it in 19 quarters.
  • Laurion Capital Management's Biogen position peaked at $39.6M in Q4 2018.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.